FOSTER JAMES ALEXANDER CUNLIFFE

PrivateCIK: 1988784
Location

LONDON, X0

FOSTER JAMES ALEXANDER CUNLIFFE enters VIRAX BIOLABS GROUP LTD with 287.99K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
IssuerVIRAX BIOLABS GROUP LTDCIK 1885827
Officer· Chief Executive Officer
Since Mar 2026
287.99K
Baseline shares
100% direct
287.99K
Direct ownership
1 position
177.25K
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned287.99K
Total
287.99K direct287.99K
Derivative Holdings5

Stock Options (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

37.25K

Shares owned

N/A

Exercise price

50.00

Expiration

Exercise window

Stock Options (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

40K

Shares owned

N/A

Exercise price

6.00

Expiration

Exercise window

Stock Options (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

50K

Shares owned

N/A

Exercise price

0.68

Expiration

Exercise window

Stock Options (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

31.98K

Shares owned

N/A

Exercise price

0.88

Expiration

Exercise window

Stock Options (right to buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

18.02K

Shares owned

N/A

Exercise price

0.88

Expiration

Exercise window

Total

Underlying

177.25K

Owned

0.00

FOSTER JAMES ALEXANDER CUNLIFFE — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho